| 11. |
- Belting, Mattias
(författare)
-
On the binding of growth-promoting polyamines to proteoglycans: Implications for growth-regulation and polycation-mediated gene transfer
- 1999
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- Initial investigations were directed at studying the interaction between polyamines and various glycosaminoglycans (GAGs). The polyamine spermine displayed binding to dermatan sulphate (DS) and heparan sulphate (HS) with similar (Kd, 3.9 x 10-4 M) and higher (Kd, 0.37 x 10-6 M) affinity, respectively, than to DNA. Antiproliferative spermine-binding DS fragments (tetra- to decasaccharides), and affinity-subfractionated HS chains were obtained by enzyme protection and affinity chromatography experiments, respectively. A clear correlation between high spermine-affinity and strong growth-inhibition was observed. Subsequent studies addressed the possible functional roles of the interaction. Pre-treatment of cells with GAG lyases, chlorate, or xylosides, all of which reduce the amount of cell-associated proteoglycans (PGs), resulted in diminished polyamine uptake. Mutant cells, deficient in PG, exhibited i) reduced polyamine uptake, ii) increased sensitivity to inhibition of polyamine biosynthesis, and iii) decreased growth-restoration by extracellular polyamines, as compared with wild-type cells. Moreover, one of the mutants exhibited the wild-type phenotype upon ectopic expression of the defective gene. The fact that several, widely used non-viral gene delivery vehicles, i.e. cationic lipids (CLs), make use of the physiological interaction between DNA and the polyamines, prompted us to investigate the possible role for PGs in CL-mediated gene transfer. Secreted PGs were shown to compete with DNA plasmid for binding to CL, leading to exchange of DNA for PG, intracellular accumulation of CL-PG complexes, nuclear deposition of GAG, and, consequently, a 100- 1000-fold decrease in reporter gene expression. In contrast, cell-associated PGs were shown to serve a protective role against CL cytotoxicity, thus allowing optimal transfection efficiency. In conclusion, the results suggest a role for PGs in 1) polyamine uptake, 2) polyamine-dependent cell growth, and 3) non-viral gene transfer.
|
|
| 12. |
|
|
| 13. |
|
|
| 14. |
- Belting, Mattias, et al.
(författare)
-
Proteoglycans as endocytosis receptors for CPPs
- 2007
-
Ingår i: Handbook of Cell-Penetrating Peptides, Second Edition. - 9780849350900 - 0849350905 ; , s. 219-219
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 15. |
- Belting, Mattias, et al.
(författare)
-
Regulation of angiogenesis by tissue factor cytoplasmic domain signaling
- 2004
-
Ingår i: Nature Medicine. - : Springer Science and Business Media LLC. - 1546-170X .- 1078-8956. ; 10:5, s. 502-509
-
Tidskriftsartikel (refereegranskat)abstract
- Hemostasis initiates angiogenesis-dependent wound healing, and thrombosis is frequently associated with advanced cancer. Although activation of coagulation generates potent regulators of angiogenesis, little is known about how this pathway supports angiogenesis in vivo. Here we show that the tissue factor (TF)-VIIa protease complex, independent of triggering coagulation, can promote tumor and developmental angiogenesis through protease-activated receptor-2 (PAR-2) signaling. In this context, the TF cytoplasmic domain negatively regulates PAR-2 signaling. Mice from which the TF cytoplasmic domain has been deleted (TFDeltaCT mice) show enhanced PAR-2-dependent angiogenesis, in synergy with platelet-derived growth factor BB (PDGF-BB). Ocular tissue from diabetic patients shows PAR-2 colocalization with phosphorylated TF specifically on neovasculature, suggesting that phosphorylation of the TF cytoplasmic domain releases its negative regulatory control of PAR-2 signaling in angiogenesis. Targeting the TF-VIIa signaling pathway may thus enhance the efficacy of angiostatic treatments for cancer and neovascular eye diseases.
|
|
| 16. |
- Belting, Mattias, et al.
(författare)
-
Role of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease.
- 2015
-
Ingår i: Journal of Internal Medicine. - : Wiley. - 1365-2796 .- 0954-6820. ; 278:3, s. 251-263
-
Forskningsöversikt (refereegranskat)abstract
- Exosomes and microvesicles, collectively referred to as extracellular vesicles (EVs), can transfer complex biological information and induce a diverse signalling response in recipient cells with potential relevance in a wide array of pathological conditions. Tissue hypoxia constitutes a stress-associated phenotype that is central to the malignant state of aggressive tumours as well as to ischaemic tissue in cardiovascular disorders. The adaptive response to hypoxic stress is largely dependent on intercellular communication in which EVs, and cellular exchange of EV cargo molecules, have recently been implicated. The results of numerous studies indicate that hypoxia-dependent shaping of the molecular profile of EVs may mediate the biological response to hypoxia. EVs have been shown to induce tumour angiogenesis and hypercoagulation as well as tissue remodelling and protective effects in ischaemic cardiovascular conditions. Recent findings report increased levels of circulating EVs in patients with hypoxia-associated disorders such as myocardial infarction, stroke and pre-eclampsia, indicating a role of EVs as biomarkers in these pathophysiological states. Here, we discuss the intriguing role of EVs in tumour development and cardiovascular disease, focusing on the paracrine transfer of the hypoxic response to neighbouring cells and to distant cells at the systemic level, with wide implications for biomarker discovery and therapeutic intervention.
|
|
| 17. |
|
|
| 18. |
|
|
| 19. |
- Belting, Mattias, et al.
(författare)
-
Tumor attenuation by combined heparan sulfate and polyamine depletion.
- 2002
-
Ingår i: Proceedings of the National Academy of Sciences. - 1091-6490. ; 99:1, s. 371-376
-
Tidskriftsartikel (refereegranskat)abstract
- Cells depend on polyamines for growth and their depletion represents a strategy for the treatment of cancer. Polyamines assemble de novo through a pathway sensitive to the inhibitor, alpha-difluoromethylornithine (DFMO). However, the presence of cell-surface heparan sulfate proteoglycans may provide a salvage pathway for uptake of circulating polyamines, thereby sparing cells from the cytostatic effect of DFMO. Here we show that genetic or pharmacologic manipulation of proteoglycan synthesis in the presence of DFMO inhibits cell proliferation in vitro and in vivo. In cell culture, mutant cells lacking heparan sulfate were more sensitive to the growth inhibitory effects of DFMO than wild-type cells or mutant cells transfected with the cDNA for the missing biosynthetic enzyme. Moreover, extracellular polyamines did not restore growth of mutant cells, but completely reversed the inhibitory effect of DFMO in wild-type cells. In a mouse model of experimental metastasis, DFMO provided in the water supply also dramatically diminished seeding and growth of tumor foci in the lungs by heparan sulfate-deficient mutant cells compared with the controls. Wild-type cells also formed tumors less efficiently in mice fed both DFMO and a xylose-based inhibitor of heparan sulfate proteoglycan assembly. The effect seemed to be specific for heparan sulfate, because a different xyloside known to affect only chondroitin sulfate did not inhibit tumor growth. Hence, combined inhibition of heparan sulfate assembly and polyamine synthesis may represent an additional strategy for cancer therapy.
|
|
| 20. |
- Belting, Mattias, et al.
(författare)
-
Vasoactive Peptides with Angiogenesis-Regulating Activity Predict Cancer Risk in Males.
- 2012
-
Ingår i: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. - 1538-7755. ; 21:3, s. 513-522
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Tumor development requires angiogenesis, and antiangiogenesis has been introduced in the treatment of cancer patients; however, how the cardiovascular phenotype correlates with cancer risk remains ill-defined. Here, we hypothesized that vasoactive peptides previously implicated in angiogenesis regulation predict long-term cancer risk.METHODS: We measured midregional proatrial natriuretic peptide (MR-proANP), proadrenomedullin (MR-proADM), and C-terminal preprovasopressin (copeptin) in fasting plasma from participants of the Malmö Diet and Cancer Study that were free from cancer prior to the baseline exam in 1991 to 1994 (1,768 males and 2,293 females). We used Cox proportional hazards models to determine the time to first cancer event in relation to baseline levels of vasoactive peptides during a median follow-up of 15 years.RESULTS: First cancer events occurred in 366 males and in 368 females. In males, one SD increase of MR-proANP, copeptin, and MR-proADM was independently related to incident cancer [HR (95% CI)] by 0.85 (0.74-0.96), P = 0.012; 1.17 (1.04-1.32), P = 0.009; and 1.12 (0.99-1.26), P = 0.065, respectively, and a summed biomarker score identified an almost 2-fold difference in cancer risk between the top and bottom quartile (P < 0.001). In younger males, the biomarker score identified a more than 3-fold increase in risk between the top and bottom quartile (P < 0.001). Among females, we found no relationship between biomarkers and cancer incidence.CONCLUSIONS: Our data suggest that vasoactive peptide biomarkers predict cancer risk in males, particularly in younger males.Impact: Our findings may have implications for cancer risk prediction and present novel, potentially drug modifiable, mechanisms underlying cancer development. Cancer Epidemiol Biomarkers Prev; 1-10. ©2012 AACR.
|
|
